[1]崔敏珺,李从圣,杨 静.高血压患者发生射血分数保留心衰的危险因素分析[J].医学信息,2019,32(20):72-76.[doi:10.3969/j.issn.1006-1959.2019.20.020]
　CUI Min-jun,LI Cong-sheng,YANG Jing.Analysis of Risk Factors for the Occurrence of Heart Failure in Patients with Hypertension[J].Journal of Medical Information,2019,32(20):72-76.[doi:10.3969/j.issn.1006-1959.2019.20.020]
点击复制

高血压患者发生射血分数保留心衰的危险因素分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年20期
页码:
72-76
栏目:
论著
出版日期:
2019-10-15

文章信息/Info

Title:
Analysis of Risk Factors for the Occurrence of Heart Failure in Patients with Hypertension
文章编号:
1006-1959（2019）20-0072-05
作者:
崔敏珺; 李从圣; 杨 静
（安徽省合肥市第一人民医院急诊内科，安徽 合肥 230061）
Author(s):
CUI Min-jun; LI Cong-sheng; YANG Jing
(Department of Emergency Internal,Hefei First People's Hospital,Anhui 230061,Hefei,China)
关键词:
高血压; 射血分数保留心衰; 危险因素
Keywords:
Hypertension; Ejection fraction preserves heart failure; Risk factors
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2019.20.020
文献标志码:
A
摘要:
目的 分析高血压患者发生射血分数保留心力衰竭的危险因素,为该类患者的预防提供参考依据。方法 回顾性分析2016年1月~2018年12月我院102例原发性高血压患者的临床资料，将高血压合并射血分数保留的心力衰竭患者50例作为观察组，以原发性高血压非心衰患者52例作为对照组，比较两组临床资料，包括性别、年龄、BMI、吸烟史、饮酒史、房颤、冠心病、糖尿病、高尿酸血症、肾功能不全、脑卒中、低血钾、血脂异常、贫血、呼吸睡眠暂停病史，分析其与高血压合并射血分数保留心衰的相关性，多因素回归分析高血压患者发生射血分数保留心衰的危险因素。结果 两组性别、BMI、年龄、吸烟史、房颤、冠心病、糖尿病、高尿酸血症、肾功能不全、贫血的发病率比较，差异有统计学意义（P＜0.05）；两组饮酒史、低血钾、脑卒中、血脂异常、呼吸睡眠暂停发病率比较，差异无统计学意义（P＞0.05）。Pearson相关性分析结果显示，性别、BMI、年龄，吸烟史、房颤、冠心病、糖尿病、高尿酸血症、肾功能不全、贫血与高血压合发生射血分数保留心衰呈正相关（P＜0.05）。Logistic多因素回归分析结果显示，女性、超重、吸烟、房颤、高尿酸血症为高血压患者发生射血分数保留心衰的独立危险因素。结论 女性、超重、吸烟、房颤、高尿酸血症为高血压合并射血分数保留心衰的危险因素。临床工作应重视对女性高血压患者基础疾病控制，同时重视对患者不良生活习惯的干预治疗，改善机体异常症状，以降低射血分数保留心衰的发生进展。
Abstract:
Objective Analysis of the risk factors of heart failure in patients with hypertension to preserve heart failure, provide a reference for the prevention of such patients.Methods A retrospective analysis of 102 patients with essential hypertension admitted to our hospital from January 2016 to December 2018, 50 patients with heart failure and hypertension with ejection fraction retained as observation group, with essential hypertension 52 patients with non-heart failure were used as the control group. The clinical data， including sex, age, BMI, smoking history, drinking history， atrial fibrillation, coronary heart disease, diabetes, hyperuricemia were compared between the two groups, renal insufficiency, stroke, hypokalemia, dyslipidemia, anemia, respiratory sleep apnea history, analysis of its association with hypertension with ejection fraction to preserve heart failure, multivariate regression analysis of high blood pressure patients with ejection fraction Preserve the risk factors for heart failure.Results There were significant differences in gender, BMI, age, and smoking history and the incidence of atrial fibrillation, coronary heart disease, diabetes, hyperuricemia, renal insufficiency, and anemia was statistically significant (P<0.05). There was no significant difference in the incidence of drinking history， hypokalemia, stroke, dyslipidemia, and respiratory sleep pauses between two groups (P>0.05). Pearson correlation analysis showed that gender, BMI, age, smoking history, atrial fibrillation, coronary heart disease, diabetes, hyperuricemia, renal insufficiency, anemia and hypertension were positively correlated with the ejection fraction to preserve heart failure (P<0.05). Logistic multivariate regression analysis showed that women, overweight, smoking, atrial fibrillation, and hyperuricemia were independent risk factors for the occurrence of heart failure in patients with hypertension.Conclusion Female, overweight, smoking, atrial fibrillation, and hyperuricemia are risk factors for hypertension and combined ejection fraction to preserve heart failure. Clinical work should pay attention to the basic disease control of female hypertensive patients, and pay attention to the intervention treatment of patients with bad living habits, improve the abnormal symptoms of the body, in order to reduce the ejection fraction and preserve the progress of heart failure.

参考文献/References:

[1]Ponikowski P,Voors AA,Anker SD,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur Heart J,2016,18(8):891-975. [2]Forouzanfar MH,Liu P,Roth GA,et al.Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mmHg,1990-2015[J].JAMA,2017,317(2):165-182. [3]孙刚,黄冠华.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,37(2):201-204. [4]田桂芳,杨秀玲,戴妍妍,等.射血分数保留的老年慢性心力衰竭患者的N末端脑钠肽前体水平及超声特点[J].中国循证心血管医学杂志,2017,9(3):345-347. [5]Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the National Cholesterol Education Program(NCEP)expert panel on detection,evaluation,and treatment of high blood cholesterol in adults(Adult Treatment Panel Ⅲ)[J].JAMA,2001,285(19),2486-2479. [6]赵昔良,叶益聪,张抒扬.美国糖尿病学会新版糖尿病诊断标准对择期冠状动脉造影患者糖代谢异常的筛查意义[J].中华内科杂志,2015,54(4):302-306. [7]Hoste L,Dubourg L,Selistre L,et al.A new equation to estimate the glomerular filtration rate in children,adolescents and young adults[J].Nephrol Dial Transplant,2014,29(5):1082-1091. [8]严玉平,伍桂枝.尿酸、高尿酸血症与缺血性卒中[J].国际脑血管病杂志,2014,22(5):392-396. [9]Greenberg B.Heart failure preserved ejection fraction with coronary artery disease:time for a new classification[J].J Am Coll Cardiol,2014,63(25 Pt A):2828-2830. [10]Remme WJ,Swedberg K.Guidelines for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22(17):1527-1560． [11]Kristensen SL,Mogensen UM,Jhund PS,et al.Clinical and Echocardioraphic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction:A Report From the I-preserve Trial(Irbesartan in Heart Failure With Preserved Ejection Fraction)[J].Circulation,2017,135(8):742-735. [12]潘庆丽.高血压患者并发心力衰竭的危险因素分析[J].慢性病学杂志,2016,17(9):1047-1049. [13]左易霞,范晋奇,殷跃辉,等.射血分数保留的心力衰竭新进展[J].心血管病学进展,2017,38(1):21-24. [14]Guo L,Guo X,Chang Y,et al.Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction:A Population-Based Study in Northeast China[J].Environmental Research and Public Health,2016,13(8):E770. [15]王淼,张强,王义围,等.老年患者射血分数保留心力衰竭与N端脑钠肽前体、超敏C反应蛋白、血尿酸及同形半胱氨酸的相关性[J].中国老年医学,2017,37(2):366-368. [16]Chen Y,Sato H,Watanabe N,et al.Factors influencing left atrial volume in treated hypertension[J].J Cardiol,2012,60(2):133-138. [17]Anter E,Jessup M,Callans DJ.Atrial fibrillation and heart failure:treatment considerations for a dual epidemic[J].Circulation,2009,119(18):2516-2525. [18]宋婷婷,贾红丹,国强华,等.老年高血压患者发生射血分数保留心衰的危险因素分析[J].川北医学院学报,2018,33(2):158-161. [19]于彤彤,刘双双,王箐箐,等.舒张性和收缩性心衰患者的临床表现差异分析[J].天津医药,2015,34(1):68-71. [20]Oluleye OW,Rector TS,Win S,et al.History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction[J].Circ Heart Fail,2014,7(6):960-966. [21]常彬宾,王建,徐超.左室射血分数保留的高龄心衰贫血患者的分析[J].临床医药文献杂志,2018,5(51):31-33. [22]常彬宾,许婷媛,徐贤华,等.铁缺乏对左室射血分数的高龄心衰患者生活质量的影响[J].西南国防医药,2018,28(7):612-614.

相似文献/References:

[1]颜 明,龚丽娜,王淑清.彩超在高血压患者肾动脉血流动力学检测中的应用分析[J].医学信息,2018,31(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
　YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Journal of Medical Information,2018,31(20):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
　XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Journal of Medical Information,2018,31(20):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(20):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]乔 君,高 翔,王 瑜,等.缬沙坦对原发性高血压患者外周PBMC中IL-17表达的影响[J].医学信息,2018,31(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
　QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Journal of Medical Information,2018,31(20):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育对原发性高血压患者治疗效果的影响[J].医学信息,2018,31(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
　DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Journal of Medical Information,2018,31(20):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
　TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Journal of Medical Information,2022,35(20):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[7]沈 正,王庆海.焦虑抑郁障碍与血压变异性研究[J].医学信息,2018,31(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
　SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Journal of Medical Information,2018,31(20):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[8]左洪亮.苯磺酸左旋氨氯地平片治疗中老年患者 轻中度原发性高血压的疗效观察[J].医学信息,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
　ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Journal of Medical Information,2018,31(20):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[9]袁 敏,周袁成.钙离子拮抗剂类降压药的临床应用与不良反应分析[J].医学信息,2018,31(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
　YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Journal of Medical Information,2018,31(20):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
[10]陈学军,李 敏,张 丹,等.社区一体化分级管理模式对社区老年高血压患者的管理效果[J].医学信息,2018,31(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
　CHEN Xue-jun,LI Min,ZHANG Dan,et al.Management Effect of Community Integration Hierarchical Management Mode on Elderly Hypertensive Patients in Community[J].Journal of Medical Information,2018,31(20):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]

更新日期/Last Update: 2019-10-15